{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:27:08Z","timestamp":1774020428785,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00415-023-12090-6","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T11:02:49Z","timestamp":1701169369000},"page":"1-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19"],"prefix":"10.1007","volume":"271","author":[{"given":"K. Z. A.","family":"Domingues","sequence":"first","affiliation":[]},{"given":"A. F.","family":"Cobre","sequence":"additional","affiliation":[]},{"given":"R. E. L.","family":"Lazo","sequence":"additional","affiliation":[]},{"given":"L. S.","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"L. M.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"F. S.","family":"Tonin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"R.","family":"Pontarolo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"12090_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells11081298","volume":"11","author":"K Choe","year":"2022","unstructured":"Choe K, Park HY, Ikram M, Al E (2022) Systematic review of the common pathophysiological mechanisms in COVID-19 and neurodegeneration\u202f: the role of bioactive compounds and natural antioxidants. Cells 11:1\u201324","journal-title":"Cells"},{"issue":"7869","key":"12090_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/d41586-021-02039-y","volume":"595","author":"M Scudellari","year":"2022","unstructured":"Scudellari M (2022) How the coronavirus infects cells\u2014and why Delta is so dangerous. Nature 595(7869):640\u2013644. https:\/\/doi.org\/10.1038\/d41586-021-02039-y","journal-title":"Nature"},{"key":"12090_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00453-w","author":"T Solomon","year":"2021","unstructured":"Solomon T (2021) Neurological infection with SARS-CoV-2 - the story so far. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/s41582-020-00453-w","journal-title":"Nat Rev Neurol"},{"key":"12090_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.1038908","volume":"12","author":"S Semiz","year":"2022","unstructured":"Semiz S (2022) COVID19 biomarkers: What did we learn from systematic reviews? Front Cell Infect Microbiol 12:1\u201315. https:\/\/doi.org\/10.3389\/fcimb.2022.1038908","journal-title":"Front Cell Infect Microbiol"},{"key":"12090_CR5","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/acn3.51166","volume":"7","author":"J Almqvist","year":"2020","unstructured":"Almqvist J, Granberg T, Tzortzakakis A et al (2020) Neurological manifestations of coronavirus infections\u2014a systematic review. Ann Clin Transl Neurol 7:2057\u20132071. https:\/\/doi.org\/10.1002\/acn3.51166","journal-title":"Ann Clin Transl Neurol"},{"key":"12090_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00415-020-10067-3","volume":"268","author":"X Chen","year":"2021","unstructured":"Chen X, Laurent S, Onur OA et al (2021) A systematic review of neurological symptoms and complications of COVID-19. J Neurol 268:392\u2013402. https:\/\/doi.org\/10.1007\/s00415-020-10067-3","journal-title":"J Neurol"},{"key":"12090_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2478\/amb-2021-0035","volume":"48","author":"MH Zamanian","year":"2021","unstructured":"Zamanian MH, Janbakhsh A, Mansouri F et al (2021) Neurological manifestations of hospitalized patients with covid-19: a case series study. Acta Medica Bulg 48:41\u201345. https:\/\/doi.org\/10.2478\/amb-2021-0035","journal-title":"Acta Medica Bulg"},{"issue":"2","key":"12090_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.53854\/liim-3102-2","volume":"31","author":"RG Menezes","year":"2023","unstructured":"Menezes RG, Alabduladhem TO, Siddiqi AK et al (2023) Cerebrovascular disease in COVID-19: a systematic review and meta-analysis. Le Infezioni in Medicina 31(2):140\u2013150. https:\/\/doi.org\/10.53854\/liim-3102-2","journal-title":"Le Infezioni in Medicina"},{"key":"12090_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1515\/revneuro-2021-0130","volume":"33","author":"C Quintanilla-s\u00e1nchez","year":"2022","unstructured":"Quintanilla-s\u00e1nchez C, Salcido-montenegro A, Gonz\u00e1lez-Gonz\u00e1lez JG, Rodr\u00edguez-Guti\u00e9rrez R (2022) Acute cerebrovascular events in severe and nonsevere COVID-19 patients\u202f: a systematic review and meta-analysis. Rev Neurosci 33:631\u2013639. https:\/\/doi.org\/10.1515\/revneuro-2021-0130","journal-title":"Rev Neurosci"},{"key":"12090_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/braincomms\/fcab297","volume":"1","author":"JB Badenoch","year":"2021","unstructured":"Badenoch JB, Rengasamy ER, Watson C et al (2021) Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun 1:1\u201315. https:\/\/doi.org\/10.1093\/braincomms\/fcab297","journal-title":"Brain Commun"},{"key":"12090_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F, Ling S, Lui LMW et al (2022) Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93\u2013135","journal-title":"Brain Behav Immun"},{"key":"12090_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff D, Sun A, Ssentongo AE et al (2021) Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection a systematic review. JAMA Netw Open 4:1\u201317. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28568","journal-title":"JAMA Netw Open"},{"key":"12090_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.857573","volume":"13","author":"D Battaglini","year":"2022","unstructured":"Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC et al (2022) Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front Immunol 13:1\u201311. https:\/\/doi.org\/10.3389\/fimmu.2022.857573","journal-title":"Front Immunol"},{"key":"12090_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0269005","volume":"17","author":"M Lampart","year":"2022","unstructured":"Lampart M, Zellweger N, Bassetti S et al (2022) Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections\u2014a prospective cohort study. PLoS ONE 17:1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0269005","journal-title":"PLoS ONE"},{"key":"12090_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2020.607647","volume":"8","author":"M Samprathi","year":"2021","unstructured":"Samprathi M, Jayashree M (2021) Biomarkers in COVID-19: an up-to-date review. Front Pediatr 8:1\u201312. https:\/\/doi.org\/10.3389\/fped.2020.607647","journal-title":"Front Pediatr"},{"key":"12090_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2019","unstructured":"Hickman S, Izzy S, Sen P et al (2019) Microglia in neurodegeneration. Nat Neurosci 21:1359\u20131369. https:\/\/doi.org\/10.1038\/s41593-018-0242-x","journal-title":"Nat Neurosci"},{"key":"12090_CR17","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00415-023-11768-1","volume":"270","author":"A Abdelhak","year":"2023","unstructured":"Abdelhak A, Barba L, Romoli M et al (2023) Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis. J Neurol 270:3315\u20133328. https:\/\/doi.org\/10.1007\/s00415-023-11768-1","journal-title":"J Neurol"},{"key":"12090_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000238","volume":"2","author":"J Cooper","year":"2020","unstructured":"Cooper J, Stukas S, Hoiland RL et al (2020) Quantification of neurological blood-based biomarkers in critically ill patients with coronavirus disease 2019. Crit care Explor 2:e0238. https:\/\/doi.org\/10.1097\/CCE.0000000000000238","journal-title":"Crit care Explor"},{"key":"12090_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.tips.2020.09.011","volume":"41","author":"L Gaetani","year":"2020","unstructured":"Gaetani L, Paolini Paoletti F, Bellomo G et al (2020) CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment. Trends Pharmacol Sci 41:1023\u20131037. https:\/\/doi.org\/10.1016\/j.tips.2020.09.011","journal-title":"Trends Pharmacol Sci"},{"key":"12090_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","volume":"867","author":"MA Isgr\u00f2","year":"2015","unstructured":"Isgr\u00f2 MA, Bottoni P, Scatena R (2015) Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol 867:125\u2013143. https:\/\/doi.org\/10.1007\/978-94-017-7215-0_9","journal-title":"Adv Exp Med Biol"},{"key":"12090_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/ene.14491","volume":"28","author":"P Perrin","year":"2020","unstructured":"Perrin P, Collongues N, Baloglu S et al (2020) Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol 28:248\u2013258. https:\/\/doi.org\/10.1111\/ene.14491","journal-title":"Eur J Neurol"},{"key":"12090_CR22","doi-asserted-by":"publisher","first-page":"E3019","DOI":"10.1093\/cid\/ciaa1933","volume":"73","author":"A Pilotto","year":"2021","unstructured":"Pilotto A, Masciocchi S, Volonghi I et al (2021) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin Infect Dis 73:E3019\u2013E3026. https:\/\/doi.org\/10.1093\/cid\/ciaa1933","journal-title":"Clin Infect Dis"},{"key":"12090_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.26135","volume":"90","author":"HY Chung","year":"2021","unstructured":"Chung HY, Neu C, Wickel J et al (2021) Neurofilament light chain in patients with COVID-19 and bacterial pneumonia. Ann Neurol 90:174\u2013175. https:\/\/doi.org\/10.1002\/ana.26135","journal-title":"Ann Neurol"},{"key":"12090_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/acn3.51542","volume":"9","author":"RR Masvekar","year":"2022","unstructured":"Masvekar RR, Kosa P, Jin K et al (2022) Prognostic value of serum\/plasma neurofilament light chain for COVID-19-associated mortality. Ann Clin Transl Neurol 9:622\u2013632. https:\/\/doi.org\/10.1002\/acn3.51542","journal-title":"Ann Clin Transl Neurol"},{"key":"12090_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/jnc.15585","volume":"161","author":"OJ Ziff","year":"2022","unstructured":"Ziff OJ, Ashton NJ, Mehta PR et al (2022) Amyloid processing in COVID-19-associated neurological syndromes. J Neurochem 161:146\u2013157. https:\/\/doi.org\/10.1111\/jnc.15585","journal-title":"J Neurochem"},{"key":"12090_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3233\/JAD-181055","volume":"78","author":"M Boldrini","year":"2021","unstructured":"Boldrini M, Canoll P, Klein R (2021) How COVID-19 Affects the Brain. J Alzheimer\u2019s Dis 78:682\u2013683. https:\/\/doi.org\/10.3233\/JAD-181055","journal-title":"J Alzheimer\u2019s Dis"},{"key":"12090_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1085988","author":"YJ Lai","year":"2023","unstructured":"Lai YJ, Liu SH, Manachevakul S et al (2023) Biomarkers in long COVID-19: A systematic review. Front Med. https:\/\/doi.org\/10.3389\/fmed.2023.1085988","journal-title":"Front Med"},{"key":"12090_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abst.2020.08.001","volume":"2","author":"L Zhang","year":"2020","unstructured":"Zhang L, Guo H (2020) Biomarkers of COVID-19 and technologies to combat SARS-CoV-2. Adv Biomark Sci Technol 2:1\u201323. https:\/\/doi.org\/10.1016\/j.abst.2020.08.001","journal-title":"Adv Biomark Sci Technol"},{"key":"12090_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions. Cochrane Handb Syst Rev Interv. https:\/\/doi.org\/10.1002\/9781119536604","journal-title":"Cochrane Handb Syst Rev Interv"},{"key":"12090_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"12090_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2019-033509","volume":"10","author":"CM Ribeiro","year":"2020","unstructured":"Ribeiro CM, Beserra BTS, Silva NG et al (2020) Exposure to endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and meta-analysis. BMJ Open 10:1\u20132. https:\/\/doi.org\/10.1136\/bmjopen-2019-033509","journal-title":"BMJ Open"},{"key":"12090_CR32","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/pm\/pnab341","volume":"23","author":"R Magdy","year":"2022","unstructured":"Magdy R, Eid RA, Fathy W et al (2022) Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med 23:774\u2013781","journal-title":"Pain Med"},{"key":"12090_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.724022","author":"JA Matias-Guiu","year":"2021","unstructured":"Matias-Guiu JA, Delgado-Alonso C, Yus M et al (2021) \u201cBrain Fog\u201d by COVID-19 or Alzheimer\u2019s Disease? A case report. Front Psychol. https:\/\/doi.org\/10.3389\/fpsyg.2021.724022","journal-title":"Front Psychol"},{"key":"12090_CR34","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1212\/WNL.0000000000010977","volume":"96","author":"A Ed\u00e9n","year":"2021","unstructured":"Ed\u00e9n A, Kanberg N, Gostner J et al (2021) CSF biomarkers in patients with COVID-19 and neurologic symptoms: a case series. Neurology 96:e294\u2013e300. https:\/\/doi.org\/10.1212\/WNL.0000000000010977","journal-title":"Neurology"},{"key":"12090_CR35","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1007\/s00415-021-10560-3","volume":"268","author":"M Morassi","year":"2021","unstructured":"Morassi M, Palmerini F, Nici S et al (2021) SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients. J Neurol 268:3980\u20133987. https:\/\/doi.org\/10.1007\/s00415-021-10560-3","journal-title":"J Neurol"},{"key":"12090_CR36","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s40200-022-01138-5","volume":"21","author":"G Shafiee","year":"2022","unstructured":"Shafiee G, Arastou T, Heshmat R et al (2022) Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-\u03b1 inhibitors: a case series study. J Diabetes Metab Disord 21:2013\u20132016. https:\/\/doi.org\/10.1007\/s40200-022-01138-5","journal-title":"J Diabetes Metab Disord"},{"key":"12090_CR37","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1007\/s00415-021-10517-6","volume":"268","author":"AH Aamodt","year":"2021","unstructured":"Aamodt AH, H\u00f8gest\u00f8l EA, Popperud TH et al (2021) Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19. J Neurol 268:3574\u20133583. https:\/\/doi.org\/10.1007\/s00415-021-10517-6","journal-title":"J Neurol"},{"key":"12090_CR38","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1007\/s00415-020-10050-y","volume":"267","author":"M Ameres","year":"2020","unstructured":"Ameres M, Brandstetter S, Toncheva AA et al (2020) Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. J Neurol 267:3476\u20133478. https:\/\/doi.org\/10.1007\/s00415-020-10050-y","journal-title":"J Neurol"},{"key":"12090_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1070379","author":"V Bonetto","year":"2022","unstructured":"Bonetto V, Pasetto L, Lisi I et al (2022) Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1070379","journal-title":"Front Immunol"},{"key":"12090_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12026-021-09220-5","volume":"69","author":"S Bozzetti","year":"2021","unstructured":"Bozzetti S, Ferrari S, Zanzoni S et al (2021) Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? Immunol Res 69:553\u2013557. https:\/\/doi.org\/10.1007\/s12026-021-09220-5","journal-title":"Immunol Res"},{"key":"12090_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neurol.2022.11.002","volume":"179","author":"H Chaumont","year":"2023","unstructured":"Chaumont H, Kaczorowski F, San-Galli A et al (2023) Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes. Rev Neurol (Paris) 179:208\u2013217. https:\/\/doi.org\/10.1016\/j.neurol.2022.11.002","journal-title":"Rev Neurol (Paris)"},{"key":"12090_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.13253","volume":"5","author":"A Ed\u00e9n","year":"2022","unstructured":"Ed\u00e9n A, Grahn A, Bremell D et al (2022) Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Netw open 5:e2213253. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13253","journal-title":"JAMA Netw open"},{"key":"12090_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42466-021-00116-1","volume":"3","author":"U Ermis","year":"2021","unstructured":"Ermis U, Rust MI, Bungenberg J et al (2021) Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients. Neurol Res Pract 3:1\u201312. https:\/\/doi.org\/10.1186\/s42466-021-00116-1","journal-title":"Neurol Res Pract"},{"key":"12090_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/https","volume":"14","author":"M Fleischer","year":"2021","unstructured":"Fleischer M, K\u00f6hrmann M, Dolff S et al (2021) Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. Ther Adv Neurol Disord Orig 14:1\u201314. https:\/\/doi.org\/10.1177\/https","journal-title":"Ther Adv Neurol Disord Orig"},{"key":"12090_CR45","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.clinph.2021.03.016","volume":"132","author":"R Frithiof","year":"2021","unstructured":"Frithiof R, Rostami E, Kumlien E et al (2021) Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: a prospective study. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 132:1733\u20131740. https:\/\/doi.org\/10.1016\/j.clinph.2021.03.016","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"12090_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117517","author":"MA Garcia","year":"2021","unstructured":"Garcia MA, Barreras PV, Lewis A et al (2021) Cerebrospinal fluid in COVID-19 neurological complications: neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2021.117517","journal-title":"J Neurol Sci"},{"key":"12090_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866153","volume":"13","author":"M Guasp","year":"2022","unstructured":"Guasp M, Mu\u00f1oz-S\u00e1nchez G, Mart\u00ednez-Hern\u00e1ndez E et al (2022) CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front Immunol 13:866153. https:\/\/doi.org\/10.3389\/fimmu.2022.866153","journal-title":"Front Immunol"},{"key":"12090_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.26502\/fccm.92920221.Serum","volume":"5","author":"M Hay","year":"2021","unstructured":"Hay M, Ryan L, Huentelman M et al (2021) Serum neurofilament light is elevated in COVID-19 positive adults in the ICU and is associated with co-morbid cardiovascular disease, neurological complications, and acuity of illness. Cardiol Cardiovasc 5:551\u2013565. https:\/\/doi.org\/10.26502\/fccm.92920221.Serum","journal-title":"Cardiol Cardiovasc"},{"key":"12090_CR49","doi-asserted-by":"publisher","first-page":"175628642210805","DOI":"10.1177\/17562864221080528","volume":"15","author":"C Hirzel","year":"2022","unstructured":"Hirzel C, Grandgirard D, Surial B et al (2022) Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response. Ther Adv Neurol Disord 15:17562864221080528. https:\/\/doi.org\/10.1177\/17562864221080528","journal-title":"Ther Adv Neurol Disord"},{"key":"12090_CR50","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1212\/WNL.0000000000010111","volume":"95","author":"N Kanberg","year":"2020","unstructured":"Kanberg N, Ashton NJ, Andersson LM et al (2020) Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology 95:e1754\u2013e1759. https:\/\/doi.org\/10.1212\/WNL.0000000000010111","journal-title":"Neurology"},{"key":"12090_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032715","author":"MP Lennol","year":"2023","unstructured":"Lennol MP, Ashton NJ, Moreno-P\u00e9rez O et al (2023) Transient changes in the plasma of astrocytic and neuronal injury biomarkers in COVID-19 patients without neurological syndromes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032715","journal-title":"Int J Mol Sci"},{"key":"12090_CR52","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1093\/brain\/awac321","volume":"145","author":"EJ Needham","year":"2022","unstructured":"Needham EJ, Ren AL, Digby RJ et al (2022) Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain 145:4097\u20134107. https:\/\/doi.org\/10.1093\/brain\/awac321","journal-title":"Brain"},{"key":"12090_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.929480","author":"G Pellitteri","year":"2022","unstructured":"Pellitteri G, Surcinelli A, De Martino M et al (2022) Sleep alterations following COVID-19 are associated with both neuroinflammation and psychological disorders, although at different times. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.929480","journal-title":"Front Neurol"},{"key":"12090_CR54","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200003","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, Sans HM, Forman CA et al (2022) Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200003","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12090_CR55","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jnnp-2022-329933","volume":"93","author":"D Plantone","year":"2022","unstructured":"Plantone D, Locci S, Bergantini L et al (2022) Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J Neurol Neurosurg Psychiatry 93:1343\u20131348. https:\/\/doi.org\/10.1136\/jnnp-2022-329933","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12090_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abi7643","volume":"13","author":"M Prudencio","year":"2021","unstructured":"Prudencio M, Erben Y, Marquez CP et al (2021) Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci Transl Med 13:1\u201310","journal-title":"Sci Transl Med"},{"key":"12090_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120324","volume":"439","author":"BE Sahin","year":"2022","unstructured":"Sahin BE, Celikbilek A, Kocak Y et al (2022) Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J Neurol Sci 439:120324. https:\/\/doi.org\/10.1016\/j.jns.2022.120324","journal-title":"J Neurol Sci"},{"key":"12090_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28240","volume":"95","author":"BE Sahin","year":"2023","unstructured":"Sahin BE, Celikbilek A, Kocak Y et al (2023) Neurological symptoms and neuronal damage markers in acute COVID-19: Is there a correlation? A pilot study. J Med Virol 95:e28240. https:\/\/doi.org\/10.1002\/jmv.28240","journal-title":"J Med Virol"},{"key":"12090_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-023-01119-1","author":"RC Silva","year":"2023","unstructured":"Silva RC, da Rosa MM, Le\u00e3o HI et al (2023) Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil. J Neurovirol. https:\/\/doi.org\/10.1007\/s13365-023-01119-1","journal-title":"J Neurovirol"},{"key":"12090_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10020386","volume":"10","author":"B Sun","year":"2021","unstructured":"Sun B, Tang N, Peluso MJ et al (2021) Characterization and biomarker analyses of Post-COVID-19 complications and neurological manifestations. Cells 10:1\u201317","journal-title":"Cells"},{"key":"12090_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11233-5","author":"F Verde","year":"2022","unstructured":"Verde F, Milone I, Bulgarelli I et al (2022) Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations. J Neurol. https:\/\/doi.org\/10.1007\/s00415-022-11233-5","journal-title":"J Neurol"},{"key":"12090_CR62","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1111\/ene.14703","volume":"28","author":"J Virhammar","year":"2021","unstructured":"Virhammar J, N\u00e4\u00e4s A, F\u00e4llmar D et al (2021) Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Eur J Neurol 28:3324\u20133331. https:\/\/doi.org\/10.1111\/ene.14703","journal-title":"Eur J Neurol"},{"key":"12090_CR63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/acn3.51496","volume":"9","author":"J Bungenberg","year":"2022","unstructured":"Bungenberg J, Humkamp K, Hohenfeld C et al (2022) Long COVID-19: Objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol 9:141\u2013154. https:\/\/doi.org\/10.1002\/acn3.51496","journal-title":"Ann Clin Transl Neurol"},{"key":"12090_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00415-021-10694-4","volume":"269","author":"F Cavallieri","year":"2022","unstructured":"Cavallieri F, Fioravanti V, Toschi G et al (2022) COVID-19 and Parkinson\u2019s disease: a casual association or a possible second hit in neurodegeneration? J Neurol 269:59\u201361. https:\/\/doi.org\/10.1007\/s00415-021-10694-4","journal-title":"J Neurol"},{"key":"12090_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00415-020-10070-8","volume":"268","author":"L Ferini-Strambi","year":"2021","unstructured":"Ferini-Strambi L, Salsone M (2021) COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol 268:409\u2013419. https:\/\/doi.org\/10.1007\/s00415-020-10070-8","journal-title":"J Neurol"},{"key":"12090_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00415-022-11398-z","volume":"270","author":"\u00c1 Planchuelo-G\u00f3mez","year":"2023","unstructured":"Planchuelo-G\u00f3mez \u00c1, Garc\u00eda-Azor\u00edn D, Guerrero \u00c1L et al (2023) Structural brain changes in patients with persistent headache after COVID-19 resolution. J Neurol 270:13\u201331. https:\/\/doi.org\/10.1007\/s00415-022-11398-z","journal-title":"J Neurol"},{"key":"12090_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","volume":"87","author":"EA Troyer","year":"2020","unstructured":"Troyer EA, Kohn JN, Hong S (2020) Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun 87:34\u201339. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.027","journal-title":"Brain Behav Immun"},{"key":"12090_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2017.4913","volume":"1","author":"L Evered","year":"2018","unstructured":"Evered L, Silbert B, Scott DA et al (2018) Association of changes in plasma neurofilament light and Tau levels with anesthesia and surgery. JAMA Neurol 1:1\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4913","journal-title":"JAMA Neurol"},{"key":"12090_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P et al (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2018-320106","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12090_CR70","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577\u2013589. https:\/\/doi.org\/10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"key":"12090_CR71","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S et al (2022) Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol 18:158\u2013172. https:\/\/doi.org\/10.1038\/s41582-021-00616-3","journal-title":"Nat Rev Neurol"},{"key":"12090_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M (2015) Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol 32:121\u2013130. https:\/\/doi.org\/10.1016\/j.ceb.2015.02.004","journal-title":"Curr Opin Cell Biol"},{"key":"12090_CR73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1590\/0004-282X-ANP-2021-0117","volume":"80","author":"RB Domingues","year":"2022","unstructured":"Domingues RB, de Moura Leite FBV, Senne C (2022) Cerebrospinal fluid analysis in patients with COVid-19-associated central nervous system manifestations: a systematic review. Arq Neuropsiquiatr 80:296\u2013305. https:\/\/doi.org\/10.1590\/0004-282X-ANP-2021-0117","journal-title":"Arq Neuropsiquiatr"},{"key":"12090_CR74","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1042\/BCJ20160082","volume":"473","author":"P Bishop","year":"2016","unstructured":"Bishop P, Rocca D, Henley JM (2016) Ubiquitin C-Terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J 473:2453\u20132462. https:\/\/doi.org\/10.1042\/BCJ20160082","journal-title":"Biochem J"},{"key":"12090_CR75","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.14574","volume":"148","author":"F Michetti","year":"2019","unstructured":"Michetti F, D\u2019Ambrosi N, Toesca A et al (2019) The S100B story: from biomarker to active factor in neural injury. J Neurochem 148:168\u2013187. https:\/\/doi.org\/10.1111\/jnc.14574","journal-title":"J Neurochem"},{"key":"12090_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2017.00300","volume":"8","author":"EP Thelin","year":"2017","unstructured":"Thelin EP, Zeiler FA, Ercole A et al (2017) Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol 8:1\u201323. https:\/\/doi.org\/10.3389\/fneur.2017.00300","journal-title":"Front Neurol"},{"key":"12090_CR77","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","volume":"126","author":"B Gong","year":"2006","unstructured":"Gong B, Cao Z, Zheng P et al (2006) Ubiquitin hydrolase Uch-L1 rescues \u03b2-amyloid-induced decreases in synaptic function and contextual memory. Cell 126:775\u2013788. https:\/\/doi.org\/10.1016\/j.cell.2006.06.046","journal-title":"Cell"},{"key":"12090_CR78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0885066620951426","volume":"36","author":"MA Ammar","year":"2021","unstructured":"Ammar MA, Sacha GL, Welch SC et al (2021) Sedation, analgesia, and paralysis in COVID-19 patients in the setting of drug shortages. J Intensive Care Med 36:157\u2013174. https:\/\/doi.org\/10.1177\/0885066620951426","journal-title":"J Intensive Care Med"},{"key":"12090_CR79","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1007\/s00415-021-10581-y","volume":"268","author":"AL Ren","year":"2021","unstructured":"Ren AL, Digby RJ, Needham EJ (2021) Neurological update: COVID-19. J Neurol 268:4379\u20134387. https:\/\/doi.org\/10.1007\/s00415-021-10581-y","journal-title":"J Neurol"},{"key":"12090_CR80","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.seizure.2020.10.014","volume":"83","author":"AR Antony","year":"2020","unstructured":"Antony AR, Haneef Z (2020) Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure 83:234\u2013241. https:\/\/doi.org\/10.1016\/j.seizure.2020.10.014","journal-title":"Seizure"},{"key":"12090_CR81","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/emermed-2020-210380","volume":"38","author":"DT Arnold","year":"2021","unstructured":"Arnold DT, Attwood M, Barratt S et al (2021) Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study. Emerg Med J 38:543\u2013548. https:\/\/doi.org\/10.1136\/emermed-2020-210380","journal-title":"Emerg Med J"},{"key":"12090_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094830","author":"M Fabris","year":"2022","unstructured":"Fabris M, Del Ben F, Sozio E et al (2022) Cytokines from bench to bedside: a retrospective study identifies a definite panel of biomarkers to early assess the risk of negative outcome in COVID-19 patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094830","journal-title":"Int J Mol Sci"},{"key":"12090_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.830715","volume":"13","author":"E Martynova","year":"2022","unstructured":"Martynova E, Hamza S, Markelova M et al (2022) Immunogenic SARS-CoV-2 S and N protein peptide and cytokine combinations as biomarkers for early prediction of fatal COVID-19. Front Immunol 13:1\u201312. https:\/\/doi.org\/10.3389\/fimmu.2022.830715","journal-title":"Front Immunol"},{"key":"12090_CR84","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s00415-022-11030-0","volume":"269","author":"A Achiron","year":"2022","unstructured":"Achiron A, Mandel M, Gurevich M et al (2022) Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod. J Neurol 269:2286\u20132292. https:\/\/doi.org\/10.1007\/s00415-022-11030-0","journal-title":"J Neurol"},{"key":"12090_CR85","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1007\/s00415-022-11188-7","volume":"269","author":"P Coelho","year":"2022","unstructured":"Coelho P, Paula A, Martins IV et al (2022) Combined central and peripheral demyelination after COVID-19 vaccination. J Neurol 269:4618\u20134622. https:\/\/doi.org\/10.1007\/s00415-022-11188-7","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12090-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12090-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12090-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T16:20:17Z","timestamp":1704471617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12090-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["12090"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12090-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}